RARA and acute promyelocytic leukemia: Detailed characterization of mutant forms of PML and PML-RARA found in APL patients refractory to arsenic treatment offers an opportunity to expand our understanding of arsenic-induced PML degradation by exploring the underlying causes of their loss of function.